Abstract: Mycolic acids constitute the waxy layer of the outer cell wall of Mycobacterium spp and a few other genera. They are diverse in structure, providing a unique chromatographic foot-print for almost each of the more than seventy Mycobacterium species. Although mainly esterified to cell wall arabinogalactan, trehalose or glucose, some free mycolic acid is secreted during in vitro growth of M. tuberculosis. In M. tuberculosis, alpha-, keto-and methoxy-mycolic acids are the main classes, each differing in their ability to attract neutrophils, induce foamy macrophages or adopt an antigenic structure for antibody recognition. Of interest is their particular relationship to cholesterol, discovered by their ability to attract cholesterol, to bind Amphotericin B or to be recognised by monoclonal antibodies that cross-react with cholesterol. The structural elements that determine this diverse functionality include the carboxylic acid in the mycolic motif, as well as the nature and stereochemistry of the two functional groups in the merochain. The functional diversity of mycolic acid classes implies that much information may be contained in the selective expression and secretion of mycolic acids to establish tuberculosis after infection of the host. Their cholesteroid nature may relate to how they utilize host cholesterol for their persistent survival.
Introduction
It is approaching a hundred years since Anderson began to publish a ground-breaking series of papers on the isolation of novel lipid fractions from the extracts of cells of mycobacteria [1] . Within those extracts were the molecules now known as mycolic acids that have been found to show many unique and important biological properties. Mycolic acids (MAs) are long chain β-hydroxy fatty acids that can mostly be represented by the general formula 1 (Fig. 1 ) in which the 'mycolic motif' contains a non-functionalised long alkyl chain and the 'meromycolate chain' generally contain up to two functional groups X and Y that are described below. Mycolic acids are mainly bound to the cell wall through esters formed between the acid group and an alcohol of a sugar, often as penta-arabinose tetramycolates. They are also present as non-bound solvent extractable esters, such as trehalose monoand dimycolates (TMM and TDM), glucose monomycolate (GMM) and glycerol monomycolate, and as free mycolic acids. Mycolic acids occur in a distinct group of Gram-positive bacteria, classified in the suborder of Corynebacterineae, including the genera Mycobacterium, Nocardia, Rhodococcus and Corynebacterium, mentioned here in the order in which they contain large-and-complex to small-andsimple mycolic acids. In Corynebacterium the mycolic acids are smallest (C 28 -C 40 ) and seem only to provide a beneficial, but not life-essential permeability barrier for the exchange of nutrients and antibiotics over the cell wall [2] . In contrast, Mycobacterium species are fully dependent for growth and survival in vitro and in vivo on their mycolic acids, which are the largest (C 60 -C 90 ) in nature [3, 4] .
Rhodococcus has mycolic acids in the size range C 30 -C 54 , and Nocardia in the size range C 42 -C 66 but in both cases with no functional groups in the mero-chain other than the possibility of one or more double bonds [5, 6, 7, 8] .
In the pathogenic mycobacteria, such as M. tuberculosis and M. leprae, mycolic acids have distal chiral, oxygenated and proximal and/or distal chiral, non-oxygenated functional groups in the merochain defined by X and Y respectively, and different chain lengths a-d (Fig. 1) , all of which seem to endow important structural properties on the mycolic acids, which determine virulence and manipulation of the host immune response to establish a host-pathogen relationship that brings about the particular disease syndrome (eg. [9] ).
When considering the structure-function relationship of mycolic acids, it is important to put it into the context of the three ways that they are expressed by the mycobacteria, viz. as bound to the arabinogalactan of the cell wall, in cell wall extractable esters such as trehalose dimycolate (TDM), or secreted as the free mycolic acids. When mycobacterial mutants are prepared that produce modified mycolic acids due to genetically impaired or deleted enzymes, then their changed behaviour as live mycobacteria relates overall to the three ways in which they are expressed in the mycobacterium.
Examples of these are PcaA and MmaA2 mutants that express mycolic acids without α-mycolate cyclopropanation [10, 11] , CmaA2 mutants that are unable to effect trans-cyclopropanation in the oxygenated mycolates [12] , or MmaA4 and MmaA3 mutants that produce mycolic acids without distal functionality of the oxygenated mycolates [13, 14] . The significance of secreted free mycolic acids as potential role players in the manifestation of tuberculosis was recently noted when Ojha et al. (2008) [15] demonstrated their role in biofilm formation during in vitro growth of M. tuberculosis.
In this review, the focus is on the structure-function relationship of free mycolic acids, in particular their immunoregulatory and cholesteroid nature, as discovered by their isolation and chemical modification, their stereo-controlled chemical synthesis, their immune steering properties and their recognition by monoclonal and polyclonal antibodies.
Structural properties of mycolic acids of Mycobacterium species 2.1. Mycolic acid patterns characteristic of mycobacteria
The initial work on the characterization of mycolic acids from Mycobacterium tuberculosis by Asselineau and Lederer [16] , was followed by the assignment of complete overall structures to a number of classes of mycolic acid through the work of, e.g., Etemadi and Lederer and Minnikin and Polgar. Thus in 1966, the first structures of three major classes of mycolic acid, α-mycolic acid (2) [17] , keto-MA (3) and methoxy-MA (4, 5) were proposed ( Fig. 2 ) [18, 19] . The stereochemistry of the β-hydroxy-acid fragment was assigned as R,R [20, 21] . In addition, it was shown that the cyclopropane units present in α-MA, methoxy-MA or keto-MA could either have cis-stereochemistry as in (4) or α-methyl-trans-cyclopropane stereochemistry as in (5) , with the methyl substituent on the distal side of the cyclopropane from the hydroxy-acid [22, 23] .
The detailed patterns of the mycolic acid components of a number of strains of M. tuberculosis and some other mycobacteria have been elegantly collected through the work of Watanabe et al. [24, 25] . The total mixture of methyl esters was analysed first by 1 H NMR spectroscopy, then separated into α-, methoxy and ketomycolates. Each class was further split into those containing no double bonds, one trans-alkene and one cis-alkene using argentation chromatography. The detailed chain lengths could then be determined using mass spectrometry after pyrolysis to fragment the mycolic acid to produce the meromycolate fragment. For the species examined, which also included Mycobacterium bovis, Mycobacterium microti, Mycobacterium kansasii and Mycobacterium avium, the major components of each class contained cis-or trans-cyclopropanes and lacked alkenes; however, minor proportions of unsaturated compounds were also often seen. A number of strains contained tricyclopropanes with chains extended by 6 to 8 carbons. The methoxy-MA and keto-MA from most M.tuberculosis strains had minor components with additional cyclopropane rings; these were major components of the attenuated H37Ra strain which gave a different MA profile to the other Mtb strains. The MAs were categorised according to Fig. 3 . In some mycobacteria, such as Mycobacterium paratuberculosis, mycolic acids are accompanied by wax esters (6) (Fig. 2) [29] . This and earlier work showed very clearly that different mycobacteria contain different complex mixtures of mycolic acids that can provide a fingerprint. Moreover, different strains of M.tuberculosis contained significantly different components. Some selected examples are presented in Table 1 [24] . It is clear from this that there are considerable differences in each of the characteristics reported.
However, it must be noted that the strains were obtained from a range of different sources, cultured in somewhat different ways and therefore that the proportions may reflect, or certainly incorporate, factors other than simple strain differences. Thus changes in the proportion of methoxy-and keto-MA had already been reported during cultivation of Mycobacterium microti [26] . In a second landmark paper, Watanabe et al. identified and collated the positions of the functional groups in the meromycolate fragments of the MA, revealing the full complexity of the mixtures present and again showing considerable difference between H37Ra and other M.tuberculosis strains [25] . Table 2 lists the major components of the series of homologues identified for M.tuberculosis that contain two functionalities X and Y in the chain. Given that there are also homologous series of compounds containing three functionalities, the overall complexity of the MA mixture is clear. The structures in Table 2 represent the major components of a series of homologues in each case.
The orientations of the substituents relative to the hydroxy-acid part are as shown in Fig. 3 . In addition there are homologous series of mycolic acids containing three functionalities in the chain.
The direct analysis of in-tact mycolic acids by MALDI mass spectrometry was first reported by [28] .
The mycolic acids of Mycobacterium paratuberculosis are interesting because they contain no methoxy-MA but instead 'wax esters' (6) apparently derived by a Baeyer-Villiger type oxidation of keto-mycolates (Fig. 2 ) [29] .
The major MAs of Mycobacterium smegmatis are a homologous, alpha΄-series containing just a cis-alkene in the mero-chain [30] [31] [32] . In addition there are two series, one containing two cisalkenes, the other an α-methyl-trans-alkene in the proximal position and a cis-alkene at the distal position [33] . Similar series of compounds containing four or five cis-alkenes have been reported
for Mycobacterium thamnopheos [34] .
Three types of MA have been observed in Mycobacterium aurum. The first is di-unsaturated. The second series are keto-MA but the proximal group is either a cis-or an α-methyl-trans-alkene. The third series are wax ester mycolates (having an ester at the distal position) and again either a cis-or an α-methyl-trans-alkene at the proximal position [35] . The di-unsaturated MA appears not to be biosynthetically directly related, but the wax ester mycolates appear to be derived from the keto-MA by a biochemical Baeyer-Villiger type process [36] .
Epoxy-mycolic acids were isolated from Mycobacterium fortuitum [37] , M.smegmatis [38] and a number of other species, while a novel ω-1 methoxy-MA has been reported in Mycobacterium porcinum and a number of other bacteria [39] .
Although the MA of mycobacteria have many things in common, as seen above there are also characteristic differences both in the classes of functional group present and in the balance of different chain lengths. The characteristic MA patterns of a large number of mycobacteria were collated using TLC and GC-MS of the meromycolates produced by thermal fragmentation [40, 41] . Although much of the work characterising MA has been carried out by mass spectrometry or GC-MS of meromycolates, HPLC has also been used to provide distinctive profiles of MA. A homologous series of α-mycolates from Mtb H37Ra was purified by HPLC under reverse phase conditions and each component characterised by MS, leading to the identification of 10 components with a range of chain lengths [42] . This has been extended to establish characteristic HPLC patterns that can be used to distinguish a range of mycobacteria [43, 44] . For example, the MA of M.bovis BCG can be distinguished from those of M.tuberculosis and M. bovis [45] . It can also be used to suggest the phylogenetic position of newly isolated mycobacteria [46] . By coupling HPLC to electrospray ionization quadrupole TOF-MS it is possible to provide both qualitative and semi-quantitative analysis of mycolic acids. In this way the α-MA fraction from M.bovis BCG conditions was shown to accumulate during entry to dormancy induced by oxygen deprivation, while the keto-MA fraction was almost entirely eliminated [47] .
Trehalose mycolates
A component of the tubercle bacillus known as 'cord factor' occurs in strains of M.tuberculosis which have the ability to multiply in vivo and shows a delayed toxicity to mice as well as having a definite role in virulence. Initial analysis of the active component was carried out by Noll and
Bloch [48] . Mass spectrometry of these components was described in 1967, though no molecular ions could be observed [49] . The components, trehalose dimycolate (TDM) (7), trehalose monomycolate (TMM) (8) and related sugar mycolates (Fig. 4 ) exert a number of very strong immunological effects and are able to stimulate innate, early adaptive and both humoral and cellular adaptive immunity [50] .
The distribution of cell surface glycolipids in M.tuberculosis strains has been examined by two dimensional TLC coupled to FAB-MS of the intact lipid and GC-MS of the fatty acid part. Both TDM and TMM are present in virulent and avirulent strains, whereas some other lipids are only present in virulent strains [51] .
Direct molecular mass determination of TMM from a series of mycobacteria was reported in 2005 using MALDI-TOF mass spectrometry [52] . This showed marked differences between the various species. TMM from M.tuberculosis showed a distinctive pattern with abundant odd-carbon- Since the physico-chemical properties and antigenic structure of the TDM affect the host immune responses, the detailed profiling of intact TDM represents a significant advance [53, 54] . TDM and TMM prepared from single synthetic alpha-and methoxy-mycolic acids have been reported [55] .
Other mycolate esters
Among the mycobacterial lipids presented on CD1b (see 3.1.1) are free mycolic acids and glucose monomycolate (GMM) [56] . T-cell recognition is highly specific for the precise structure of natural GMM including the glucose, the linkage of the glucose to the mycolate and the R,Rstereochemistry of the hydroxyl acid part of the mycolate [57] . Upon infection mycobacteria begin to produce GMM which provides a good indicator of local invasion. The GMM is produced more 
5-mycolyl-α-arabinofuranyosyl(1→1')-glycerol (9) (RCOOH, R'COOH = mycolic acid)
A novel 5-mycolyl-α-arabinofuranyosyl(1→1')-glycerol (9, Fig. 4 ) has been isolated from the Mycobacterium avium-Mycobacterium intracellulare complex [59] . Even a very simple monomycolylglycerol (MMG) has the ability to stimulate human dendritic cells, while a model based on just a C 32 chain has similar effects [60] .
The stereochemistry of mycolic acids
In all the cases where it has been established, the β-hydroxy-acid fragment of mycolic acids has been shown to be of R,R-absolute stereochemistry. The CH 2 (CHMe)(CHOMe)CH 2 fragment of methoxy-MA has also been shown to be of S,S-absolute stereochemistry. It has been proposed that the biosynthesis of various functionalities in MA proceeds through a common intermediate, a
cation produced by alkylation of a cis-alkene. This can then either lose a proton from the methyl group to produce a cis-cyclopropane, from an adjacent methylene group to produce a methylsubstituted trans-alkene or be trapped as an alcohol. The latter can then in turn be converted into methoxy-and keto-MA ( In support of some elements of this mechanism, the fast growing M.smegmatis normally produces oxygenated mycolic acids with an epoxy group. However, if a set of four genes from M.bovis BCG coding for methyl transferases is transferred into M.smegmatis, this produces keto-mycolic acid together with a hydroxy-mycolic acid, both of which are cyclopropanated. There is a perfect match between the structures of the keto-and hydroxy-MA [62] . More detailed analysis showed that both M.bovis BCG and M.tuberculosis also produce small amounts of hydroxy-MA and again there appears to be a direct relationship between hydroxy-MA and keto-MA [63] . Although cyclopropanated MAs were previously thought not to abound in M.smegmatis, it was recently shown that the genes to effect this are present in the genome and can be induced for expression at low temperature growth conditions [65] .
Synthetic mycolic acids
The The first synthetic mycolic acid reported was the protected α-mycolic acid (17, Fig. 6 ) [64] . Since that time, all four possible diastereomers of this di-cis-cyclopropane-MA have been synthesised.
Based on the model in Fig. 5 and assuming that both proximal and distal cyclopropanes are introduced with the same geometry, isomer 17 has the natural stereochemistry.
In the same way, three stereoisomers of the major methoxy-MA of M.tuberculosis, including (18) [66] as well as keto-mycolic acids containing both cis-and trans-cyclopropanes (19) and (20) have been reported (Fig. 6 ) [67, 68] . In addition, single synthetic MAs containing just cis-alkenes
, trans-alkenes [70] and epoxy-MA (22) [71] have been reported (Fig. 6 ).
Does structure matter?
There are a number of observations suggesting that the detailed structures of natural mycolic acids and their sugar esters are important:
· In at least Mycobacterium phlei and M. smegmatis, the balance of different classes of MA changes with the temperature at which the organism is grown, possibly to manipulate the membrane properties [65, 72] .
· Cells of mycobacteria grown at higher temperature contain increased levels of trans-MA and have a higher melting temperature; moreover, they allow a less rapid influx of some drugs [73] .
· The proportion of trans-substituted cyclopropane at the proximal position of MA is important in determining the fluidity of the cell wall. By over-expressing MMAS-1, an enzyme in the gene cluster responsible for biosynthesis of methoxy-MA, an increase was seen in the production of both trans-alkene and trans-cyclopropane mycolates, and in the proportion of keto-MA to methoxy-MA. This was accompanied by a substantially decreased growth rate at elevated temperature and an increased permeability of the cell wall [74] .
· Cyclopropane modification of M. tuberculosis cell envelope TDM is critical for bacterial growth during the first week of infection in mice. TDM isolated from a mutant deficient in the cyclopropane synthase PcaA is hypoinflammatory for macrophages and induces less severe granulatomous inflammation, showing that the fine structure of the mycolates in these lipids directly affects pathogenesis and temporal control of the host immune activation through cyclopropane modification [75] .
· TDM isolated from a mutant (∆cmaA2) that lacks the capacity for trans-cyclopropanation is five times more potent in stimulating macrophages than TDM isolated from wild-type M.
tuberculosis. This establishes cmaA2 dependent trans-cyclopropanation of MA as an activity to suppress M. tuberculosis induced inflammation and virulence. Moreover, the stereochemistry of the cyclopropane changes the interaction with the host cell to influence host innate immune responses both positively and negatively [76, 77] .
· One of the strategies used by M. tuberculosis to avoid elimination by the host is the selective repression of macrophage IL-12p40 production. The mmaA4 gene which encodes a methyl transferase required for the introduction of oxygen substituents at the distal position of MA is a key locus in this suppression. This suggests that M. tuberculosis has evolved mmaA4-derived mycolic acids into TDM to manipulate IL-12-mediated immunity and virulence [9] .
3. Structure-function relationship of free mycolic acids 3.1. Immunoregulatory properties of natural and synthetic mycolic acids Top: In infected macrophages, the acidic pH from the phagosome may promote the dissociation of cell wall-associated structures such as LAM, TDM and others, resulting in an increased exposure of cell wall mycolic acids (red stretch). The highly hydrophobic nature of the exposed mycolic acid moieties may promote spontaneous association with the phagosome membrane, thus bringing the mycolic acids in direct contact with the cytosolic cell compartment. In human macrophages, M. tuberculosis bacilli also occur outside of the phagosome in the cytosol of the infected cell. Here, enzymatic processing of TDM by serine esterases may promote the formation of free mycolic acids. Again, the highly hydrophobic nature of the free mycolic acids will promote association with intracellular membranes and/or lead to the formation of mycolic acid-containing lipid droplets. ERassociated mycolic acids may in addition be presented on the surface of the cell by the MHC I mimic, CD1. Through as yet poorly understood mechanisms, the intracellular free mycolic acids trigger signaling pathways leading to the activation and differentiation of the infected macrophage. Endocytosis of excreted mycolic acid-containing complexes by non-infected neighboring macrophages may trigger through similar pathways the activation and differentiation of the cell, hereby promoting a bystander effect. Bottom: The functions elicited by free mycolic acids are divergent and may support increased anti-bacterial defenses or increased permissiveness to infection along with tissue repair responses. Increasing evidence supports the notion that the level and type of mycolic acid oxygenation as well as the cis-and trans-cyclopropane stereochemistry are crucial in balancing these opposite macrophage functions. appeared not to be involved directly in antigen presentation as a membrane anchored protein.
Rather, it was observed to be involved with the processing of lipid antigens in lysosomes, much like the lipid transfer proteins do [80] . Some of the more complex exogenous lipids require endosomal processing, while others are loaded and presented without processing.
There is no published evidence that lipases are involved in lipid antigen processing for CD1
loading. In mice, it was shown for some glycolipid antigens that terminal sugars were removed by specific glycosidases before CD1d loading was permitted [81] , analogous to the system for glycopeptide antigen processing before presentation to T cells. Type I CD1 presents lipid antigens to T cells, which respond by polyclonal activation, suggesting a relatively wide range of specificities for antigen binding [83] In contrast, Type II CD1 molecules present lipids to Natural Killer T (NKT) cells with structurally more conserved T cell antigen receptors [84] In the early days following the discovery that human dendritic cells presented mycobacterial MA to T cell lines, it was believed that only CD4/CD8 double negative and CD8 positive T cells were responsive to the presented MA [85] . Indeed, it was shown that both these T cell types secreted IFNγ that can protect against M. tuberculosis infection [86] and could induce apoptosis of infected macrophages [87] . Later, work on MA stimulation of human T cells by
Goodrum et al. [88] used whole peripheral blood monocytes from freshly donated normal human blood, with which it was shown that CD4 single positive T cells proliferated strongest, Sieling et al. [90] reported that CD4/CD8 double negative T cells from auto-immune systemic lupus erythematosus (SLE) patients induced antibody isotype switching from IgM to IgG in a anti-cholesterol antibody activity in TB patient sera. How this may relate to the establishment of TB is discussed in more detail below. sulfolipids [105] , and the cell wall-associated lipid phthiocerol dimycocerosate [106, 107] .
MA and macrophages

Specialized immune cells, especially macrophages, mast cells and dendritic cells express
The pronounced impact on overall mycobacterial fitness of genetic approaches to describe the biological roles of mycolic acid lipids has as a consequence that it is not possible to segregate a role for free mycolic acids in manipulating host immune responses to infection. For that reason, Korf et al. addressed the relation to host immunity of M. tuberculosis mycolates by examining the interaction with macrophages of isolated mycolic acids. To overcome the poor solubility in water of the highly hydrophobic, wax-like lipids, liposomes were used as vehicles for subsequent administration into mice [108] . Following phagocytosis by murine macrophages, mycolic acids were found to colocalize with acidic phagosomes. This absence of interference with phagosome maturation and acidification is in contrast with the intact mycobacterium that generally inhibits maturation and acidification of phagocytic compartments as a strategy to promote its own survival [109, 110] . However, administration of mycolic acids to the airways mimicked other features of M. tuberculosis infection. Thus similar to the recruitment of neutrophils, monocytes and lymphocytes observed in tuberculosis patients, mycolic acids elicited an acute neutrophilic airway inflammation which was accompanied by a moderate and chronic IL-12 production [108] . Macrophages showed only a mild inflammatory activation but exhibited a strongly increased reactivity when challenged with suboptimal concentrations of heat-killed M. tuberculosis. Among others, the production of the antimicrobial enzyme, myeloperoxidase, and the inflammatory cytokine, IFN-γ were strongly induced under these conditions. Myeloperoxidase is a heme enzyme that generates reactive oxidants and has been implicated in mycobacterial killing [111] . 
Free mycolic acids in TB
The bioavailability of free mycolic acids during natural infection has been a matter of debate Synthase involved in mycolic acid synthesis [120] . M. tuberculosis biofilms containing free mycolic acid are not just an artifact from in vitro growth but have also been described in the infected organism. Within primary granulomas in guinea pig lungs microcolonies with features reminiscent of biofilms and containing extracellular mycolic acids have been described [121] . These microcolonies were detected within an acellular rim adjacent to the edge of the mineralizing central necrotic core. Free mycolic acids in these biofilms reportedly are derived from cell envelope glycosylated mycolates and are released by a trehalose dimycolate-specific serine esterase [122] . These new findings support the notion that free mycolic acids in tubercle granulomas may actively contribute to the delicate immune balance maintained in granuloma structures by exerting the divergent pro-and anti-inflammatory activities previously reported with isolated mycolic acids [108, 116, 117] .
This leaves open the important issue of the contribution or not of mycolic acids in their natural, cell wall-bound form to the innate immune response of the infected macrophage. 
The human antibody response to mycolic acids
The first report of human TB patient antibodies to mycolic acids appeared by Pan et al. in 1999 [125] .
By separating the natural mixture of MA into the three main classes by thin layer chromatography, the authors showed that methoxy-and keto-MA were more antigenic than the non-oxygenated alpha-MA.
This was confirmed by Beukes et al. in 2010 [126] , using various isomers of stereo-controlled chemically synthetic MAs and showing methoxy-MA to be the most antigenic of the three classes in TB patients. Further analysis showed MA antigenicity to be critically dependent on the fine structure Isomer 21, believed to be the closest structural representative of the naturally occurring methoxy-MA of this chain length, was comparatively poorly recognized by TB patient sera. Converting its proximal cis-cyclopropane to a methyl-trans cyclopropane (isomer 26) made it the strongest antigenic isomer of the five that were compared in the figure. Antigenicity was also found to depend critically on the structure of the mycolic motif. In particular, methyl esterification of the carboxylic acid in the motif destroyed antigenicity altogether [126] , possibly indicating a critical role of the carboxylic acid in stabilizing an antigenic conformational fold of the MA by hydrogen bonding with the oxygenated distal functional group.
Currently, TB diagnosis in HIV burdened populations poses one of the most challenging hurdles towards regaining control of the TB epidemic [127, 128] . The potential for detection of antibodies to MA as biomarker for diagnosis of active TB was emphasized when Schleicher et al. [129] demonstrated in 2002 that the antibody binding signal to MA was not affected by the degree to which the patient was affected by HIV-co-infection. There remained, however, an overlap between the anti-MA antibody binding signals between TB patient and control sera that made the ELISA outcome not adequately accurate as a diagnostic indicator. One way to get around this problem was to employ modern antibody detection technology where antibody binding is detected in real time, thereby increasing the sensitivity of the reaction [92, 130] . These authors also showed that human TB patient anti-MA antibodies included IgG, by demonstrating that a significant part of the anti-MA antibody activity could be purified with Protein A affinity chromatography, known to be insensitive for IgM. structures to which antibodies from TB patient sera bound preferentially, as opposed to other more cross-reactive MA structures. The reality that is clear from the data in Fig. 8 is that none of the MA isomers examined showed any significant difference in distinguishing between sera from TB-positive and TB-negative patients. The same applied to isomers of the keto-and alpha-MA classes [126] .
Although the antibody binding activity to all the MA-isomers was higher in (pooled) TB positive patient sera than in (pooled) TB negative patient sera, the ratio of binding activity to MA between TB positive and TB negative patient sera remained similar for each MA antigen tested. Whereas this diminishes the prospects of increasing the accuracy of mycolic acid antigen based immunodiagnostic tests for TB by using particular isomers of chemically synthetic mycolic acids, it eases the necessity for defining exactly the class composition of MA antigens that is used to detect the MA-binding antibodies. These MAs may resemble early stage M. tuberculosis when the keto-MA dominates or the late stage when the methoxy-MA dominates [131] , with the only difference being slight changes in the magnitude of the signals for both MA antigen sets, with no difference in the ratio of the antibody binding signal from TB positive and TB negative patients.
Cholesteroid nature of mycolic acids
One lead towards the understanding of the cross-reactivity of MA recognition by TB patient and control sera was the observation that immobilized cholesterol in an ELISA plate could substitute for MA to produce similar antibody binding activity between TB patient and control sera [132] . The authors also showed that cholesterol was attracted to immobilized mycolic acids in an evanescent field biosensor. This could mean that a structural and/or functional relationship exists between MA and cholesterol. The demonstration that Amphotericin B, a cholesterol binding anti-fungal antibiotic, bound equally well to MA as to cholesterol gave credibility to such a notion. Later, Beukes et al.
[126] provided more direct proof by providing a recombinant scFv antibody fragment expressed from a chicken antibody gene library that recognized both MA and cholesterol, indicating that the antibody binding activity to cholesterol could be due to a true functional cross-reactivity with mycolic acids. It has been firmly established that humans generally have variable levels of IgM and IgG anticholesterol antibody activity in the circulation ( [133, 134] , thereby providing a possible explanation for the high binding activity to MA observed in TB negative patients. Alving and Wassef [135] proposed in 1999 that endotoxin, found ubiquitously in the environment, could act as a potent adjuvant for the induction of antibodies to cholesterol. The cholesterol source of antibody induction could come from localised sites of infection and inflammation where cellular debris is gathered. In particular, it was shown that HIV-infected individuals express higher amounts of anti-cholesterol antibodies, probably due to the role of cholesterol in the cholesterol-rich lipid raft where HIV is budding from the infected cells, as well as the subsequent insertion of cholesterol into the envelope of the HIV virion [136] . When patients were put on anti-retroviral treatment, the anti-cholesterol antibody titre rapidly declined.
Even if the prevalence of truly cross-reactive anti-MA and anti-cholesterol antibodies could be demonstrated in human sera, cross-reactivity could also be due to a mixture of monospecific anticholesterol and monospecific anti-MA antibodies. Such monospecific scFv specificities were also selected from the chicken antibody gene library by Beukes et al. [126] , showing that the recognition of MA by antibody does not necessarily manifest as cross-reactivity to cholesterol. Likewise, scFv antibody fragments to cholesterol did not necessarily cross-react with MA. Whether the antibody cross-reactivity observed in human TB and control patient sera is due to a mixture of monospecific antibodies, a true single antibody cross-reactivity, or both remains to be determined. What seems clear at this stage is that MA and cholesterol may not be recognized as individual haptens, but rather as molecular clusters forming multi-faceted surfaces, of which one or some facets can cross-react, while other facets may be restricted to mono-specific recognition by antibodies to either cholesterol or MA. leads to the inhibition of lysosomal delivery [143, 144] . From the perspective of the property of mycolic acids to attract cholesterol and their demonstrated release from trehalose-mycolates at the mycobacterial cell surface, one can predict that MA in the phagosomal membrane would be able to facilitate cholesterol accumulation to ensure TACO retention at the interface between the phagosomal membrane and the mycobacterial cell surface [145] .
The mycolic acids that are bound to the cell wall arabinogalactan form the inner part of an outer membrane that allows adhesion at an oil-water interface to facilitate feeding from oils and fats. This property gave Rhodococcus species potential for industrial application to clean up sites of oil pollution [137] . In Mycobacterium tuberculosis, this property is manifested as an ability to attract cholesterol into the lipid-free zone that surrounds the cell wall mycolic acid layer [146] and is at the basis of the requirement for host cell membrane cholesterol to enable entry of the bacillus into its host macrophage [139, 147] . Besides being essential for the phagocytosis of the bacterium by the macrophage, cholesterol is also used by the bacilli as an energy and carbon source that is critically linked with mycobacterial persistence [148, 149] and depends on a sufficient availability of the sterol within the host cell. Mycolic acids may in fact constitute a direct means by which intracellular M.
tuberculosis bacilli ensure a sufficient lipid import by the host macrophage. The property of MA to attract cholesterol may mean that free MA, known to be released from the bacilli for the purpose of biofilming [15, 122] , could fulfil the role of attracting cholesterol into the biofilm as a carbon source for the slow growing, persistent mycobacteria. Cholesterol is known to be able to diffuse across biological membranes along a concentration gradient without the need for specific transport mechanisms. It is therefore the ideal carbon source for a pathogen that survives by isolating itself from the host vasculature that normally provides for the pathogen's nutrient requirements. Should the mycolic acids be able also to attract cholesterol in vivo, then their function in the biofilm may well include the creation of the cholesterol concentration gradient necessary to facilitate cholesterol transfer from host to pathogen. Brzostek et al. [146] demonstrated that the ability of M. tuberculosis to attract cholesterol close to its cell wall depended on the presence of the extractable lipid component of the cell wall, which includes the free mycolic acids and the trehalose mycolates from which they are released [122] .
In their pioneering paper, Korf and colleagues [108] were the first to demonstrate that mycolic acids strongly interfered with the lipid metabolism of mouse macrophages, triggering intracellular accumulation of cholesterol, increased cell size, and multiple vacuole formation, all typical features of macrophage foam cells. Foamy macrophages containing multiple cholesterol loaded lipid bodies constitute a distinct trait of tuberculous granulomas and a safe haven for mycobacteria, since they have been found to harbor multiple bacilli [150, 151] . Induction by mycolic acids of macrophages rich in lipid bodies was further confirmed on human monocyte-derived macrophages [152] . Here, the authors further showed that oxygenated mycolic acids, mostly of the keto class, play a leading role in the observed foamy macrophage formation.
In non-pathological conditions, macrophage lipid import and export are tightly regulated processes.
Excessive cholesterol accumulation therefore is indicative of a disturbed lipid homeostasis in the cells. Liver X receptors (LXRs), LXRα and LXRβ, are master regulators of macrophage transcriptional programs involved in cholesterol homeostasis [153, 154, 155] . LXR activation by 
